Theraclion SA (TCLIF)
OTCMKTS
· Delayed Price · Currency is USD
0.320
0.00 (0.00%)
At close: Aug 26, 2024
Theraclion Revenue
Theraclion had revenue of 441.64K EUR in the half year ending June 30, 2024, with 27.46% growth. This brings the company's revenue in the last twelve months to 1.28M, down -31.40% year-over-year. In the year 2023, Theraclion had annual revenue of 1.82M with 47.49% growth.
Revenue (ttm)
1.28M EUR
Revenue Growth
-31.40%
P/S Ratio
n/a
Revenue / Employee
44.24K EUR
Employees
29
Market Cap
12.05M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.82M | 586.77K | 47.49% |
Dec 31, 2022 | 1.24M | -245.50K | -16.58% |
Dec 31, 2021 | 1.48M | 736.95K | 99.05% |
Dec 31, 2020 | 744.00K | -2.39M | -76.23% |
Dec 31, 2019 | 3.13M | 1.19M | 61.42% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
Veradigm | 1.53B |
SS Innovations International | 16.04M |
Elite Pharmaceuticals | 71.17M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
BioStem Technologies | 210.49M |
Silence Therapeutics | 21.77M |